FDA Confirms Effectiveness of Fidaxomicin

The US Food and Drug Administration confirmed that Optimer Pharmaceuticals’ new antibiotic drug, fidaxomicin, is effective in combating a bacterial infection that is the direct cause of diarrhea.

While the FDA will conduct a more thorough evaluation of the data available during its advisory panel meeting on Tuesday, the health regulator released documents in which it said that fidaxomicin was able to treat the infection, known as Clostridium difficile.

About Salmonellosis
Poor hygienic practices during cooking or handling of food products can cause this distressing infection of the intestines leading to diarrhea, cramps and fever.

Share prices of Optimer saw an 11 percent rise to $13.20 before ending the session at $13.13.

Should the drug be given approval by the FDA, then this will be the first from Optimer to reach the US market and analysts predict that the drug would fetch over $200 million in annual sales.

About Water Borne Diseases
Waterborne diseases are communicable diseases caused by diseases causing microorganisms in contaminated water. It is more prevalent during floods and in tsunami affected areas.

Source-Medindia

Giardiasis - Causes
Giardiasis is an infection of the small intestine caused by a parasite called Giardia lamblia.